As of Nov 24
| -0.06 / -0.71%|
The 2 analysts offering 12-month price forecasts for aTyr Pharma Inc have a median target of 43.00, with a high estimate of 44.00 and a low estimate of 42.00. The median estimate represents a +411.30% increase from the last price of 8.41.
The current consensus among 2 polled investment analysts is to Buy stock in aTyr Pharma Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.